Telangana CM lays foundation for Shantha’s INR 460 cr insulin manufacturing facility in Hyd

The world-class, state-of-the-art facility at Muppireddipalli will manufacture Sanofi’s Insuman, a human insulin for diabetes patients.


Telangana CM K Chandrasekhar Rao and his cabinet team along with the Sanofi and Shantha leadership team

Shantha, a Sanofi Company, announced the laying of the foundation stone in Hyderabad, by Telangana's Honourable Chief Minister, K Chandrasekhar Rao, for a new production facility to manufacture Insuman, a leading human insulin product from Sanofi's range of diabetes treatments.

Sanofi will make an investment of INR 460 crore in this insulin facility. Located in Muppireddipalli (Telangana), the facility will be equipped with the latest technology to produce Insuman.

This will be Sanofi's second plant aside from the Company's existing Insuman manufacturing plant in Frankfurt.

The construction of the 13,400 square-meter building will begin immediately, with the site fully operational by 2019.

The Honourable Chief Minister, Shri K Chandrasekhar Rao welcomed the commitment towards health, technology transfer and job creation by Shantha in Telangana State.


Previous 1 3 4 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email